Enfortumab Vedotin Shows Promise for Urothelial Carcinoma ...Middle East

News by : (Medscape) -
The antibody-drug conjugate enfortumab vedotin is superior to chemotherapy in patients with previously treated advanced urothelial carcinoma, primary results of the EV-301 trial show. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Enfortumab Vedotin Shows Promise for Urothelial Carcinoma )

Also on site :

Most Viewed News
جديد الاخبار